NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

J Cell Biol. 1998 May 18;141(4):1083-93. doi: 10.1083/jcb.141.4.1083.

Abstract

The alphavbeta3 integrin plays a fundamental role during the angiogenesis process by inhibiting endothelial cell apoptosis. However, the mechanism of inhibition is unknown. In this report, we show that integrin-mediated cell survival involves regulation of nuclear factor-kappa B (NF-kappaB) activity. Different extracellular matrix molecules were able to protect rat aorta- derived endothelial cells from apoptosis induced by serum withdrawal. Osteopontin and beta3 integrin ligation rapidly increased NF-kappaB activity as measured by gel shift and reporter activity. The p65 and p50 subunits were present in the shifted complex. In contrast, collagen type I (a beta1-integrin ligand) did not induce NF-kappaB activity. The alphavbeta3 integrin was most important for osteopontin-mediated NF-kappaB induction and survival, since adding a neutralizing anti-beta3 integrin antibody blocked NF-kappaB activity and induced endothelial cell death when cells were plated on osteopontin. NF-kappaB was required for osteopontin- and vitronectin-induced survival since inhibition of NF-kappaB activity with nonphosphorylatable IkappaB completely blocked the protective effect of osteopontin and vitronectin. In contrast, NF-kappaB was not required for fibronectin, laminin, and collagen type I-induced survival. Activation of NF-kappaB by osteopontin depended on the small GTP-binding protein Ras and the tyrosine kinase Src, since NF-kappaB reporter activity was inhibited by Ras and Src dominant-negative mutants. In contrast, inhibition of MEK and PI3-kinase did not affect osteopontin-induced NF-kappaB activation. These studies identify NF-kappaB as an important signaling molecule in alphavbeta3 integrin-mediated endothelial cell survival.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, CD / physiology*
  • Aorta
  • Apoptosis / physiology*
  • Cell Adhesion
  • Cell Survival / drug effects
  • Cell Survival / physiology*
  • Cells, Cultured
  • Collagen / pharmacology
  • Culture Media, Serum-Free
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / metabolism
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology*
  • Extracellular Matrix Proteins / pharmacology
  • I-kappa B Proteins*
  • Integrin beta3
  • Kinetics
  • Macromolecular Substances
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism*
  • Osteopontin
  • Platelet Membrane Glycoproteins / physiology*
  • Polylysine / pharmacology
  • Rats
  • Receptors, Vitronectin / physiology*
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / pharmacology
  • Sialoglycoproteins / pharmacology*
  • Signal Transduction
  • Transfection

Substances

  • Antigens, CD
  • Culture Media, Serum-Free
  • DNA-Binding Proteins
  • Extracellular Matrix Proteins
  • I-kappa B Proteins
  • Integrin beta3
  • Macromolecular Substances
  • NF-kappa B
  • Nfkbia protein, rat
  • Platelet Membrane Glycoproteins
  • Receptors, Vitronectin
  • Recombinant Proteins
  • Sialoglycoproteins
  • Spp1 protein, rat
  • Osteopontin
  • NF-KappaB Inhibitor alpha
  • Polylysine
  • Collagen